Meeting
2017 ASCO Annual Meeting
PD-L1 expression and response to neo-adjuvant chemotherapy in esophageal adenocarcinoma.
Authors
Eileen E. Parkes
Centre for Cancer Research and Cell BIology, Queen's University Belfast, Belfast, United Kingdom
Eileen E. Parkes , Jaine K. Blayney , Eamon McCarron , Rosalie V. Douglas , Leanne Stevenson , Damian McManus , Stephen McQuaid , Ken Arthur , Jacqueline James , Manuel Salto-Tellez , Fergus Noble , Timothy J Underwood , Robert O'Neill , Rebecca C. Fitzgerald , Richard D. Kennedy , Richard C. Turkington
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 4023)
DOI
10.1200/JCO.2017.35.15_suppl.4023
Abstract #
4023
Poster Bd #
15
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Molecular correlates of response to preoperative olaparib alone or with cisplatin or with durvalumab in head and neck squamous cell carcinoma (HNSCC): A Hellenic Cooperative Oncology Group study.
First Author: Amanda Psyrri
Poster
2019 Gastrointestinal Cancers Symposium
Chemoradiation-induced alteration of programmed death-ligand 1 and CD8+ tumor-infiltrating lymphocytes in rectal cancer.
First Author: Marina Baretti
Poster
2018 Gastrointestinal Cancers Symposium
Association of COX-2 expression with lymphocyte infiltration in colorectal cancer.
First Author: Zehua Wu
Poster
2016 ASCO Annual Meeting
Clinicopathological features of program death ligand-1 (PD-L1) expression with tumor-infiltrating lymphocytes (TILs), mismatch repair (MMR) and Epstein-Barr virus (EBV) status in a large cohort of gastric cancer.
First Author: Akihito Kawazoe